AR and prostate cancer: Many studies indicate that ubiquitination contributes to both AR degradation and AR transcriptional activity which is dependent on ubiquitinated residues [20,[33], [34], [35], [36]], and some ubiquitin E3 ligases targeting AR have been identified in prostate cancer.